Edna “Eti” Cukierman, co-director of the Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, was appointed chair-elect of the American Association for Cancer Research’s Tumor Microenvironment Working Group at the AACR annual meeting.
Preclinical data on a development candidate, NTX-452, a novel Werner syndrome helicase inhibitor, was presented at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, by Nimbus Therapeutics.
